According to Ishrak, who has more than 20 years in ultrasound technology development and has served as the leader of GE's ultrasound division since 1995, "GE's clinical partnerships, technology leadership and continuous investment in ultrasound allows us to invite healthcare's top physicians 'to the drawing board' to re-imagine ultrasound. Together, we're developing innovative ultrasound systems to help address some of today's most pressing healthcare issues such as improving access to quality care in rural communities and developing regions of the world, and in developed regions, shifting to an 'early health' model where technologies such as ultrasound can be used to help detect diseases earlier when they can be more effectively treated."

GE's Voluson i, LOGIQ e and Vivid e systems are FDA cleared and will become commercially available in the U.S. in June 2006. LOGIQ i is also FDA cleared with plans for commercial introduction in September 2006. Vivid i received FDA clearance in 2004 and was commercially available in early 2005.


With the introduction of its Compact Series, GE expects to double its compact ultrasound business -- delivering more than 5,000 compact Vivid, LOGIQ and Voluson ultrasound systems worldwide in 2006.


Back to HCB News

More Industry Headlines